Cargando…

HYDROXYCHLOROQUINE ATTENUATES HERG CHANNEL BY PROMOTING THE MEMBRANE CHANNEL DEGRADATION: EVIDENCES FOR QT-INTERVAL PROLONGATION IN COVID-19 PATIENTS WITH HYDROXYCHLOROQUINE TREATMENT

Detalles Bibliográficos
Autores principales:	Wang, Xiqiang, Liu, Jing, Wang, Ya, Wei, Linyan, Bu, Xiang, Liu, Xiaoxiang, Wang, Junkui, Wang, Tingzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Electrophysiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972400/ http://dx.doi.org/10.1016/S0735-1097(22)01046-4

Ejemplares similares

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
por: Zequn, Zheng, et al.
Publicado: (2021)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

USING QT INTERVAL AS A PREDICTOR OF ILLNESS ACUITY DUE TO COVID-19
por: Vangala, Adarsh S., et al.
Publicado: (2023)

Effects of hydroxychloroquine treatment on QT interval
por: Hooks, Matthew, et al.
Publicado: (2020)

System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
por: Aksel, Gökhan, et al.
Publicado: (2020)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

A Residue at the Cytoplasmic Entrance of BK-Type Channels Regulating Single-Channel Opening by Its Hydrophobicity
por: Guo, Zhaohua, et al.
Publicado: (2008)

Hydroxychloroquine and QT prolongation: reassuring data in approved indications
por: Pareek, Anil, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Hydroxychloroquine: Electrical storm and QT interval prolongation following off-label use: case report
Publicado: (2020)

COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels
por: Szendrey, Mark, et al.
Publicado: (2021)

Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients
por: Eftekhar, Seyed Parsa, et al.
Publicado: (2021)

Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block
por: Tran, Phu N., et al.
Publicado: (2020)

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
por: Sridhar, Arun R., et al.
Publicado: (2020)

hERG channel function: beyond long QT
por: Babcock, Joseph J, et al.
Publicado: (2013)

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021)

Hydroxychloroquine: QT prolongation due to off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

THE EFFECT OF TREATMENT WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ON THE CORRECTED QT INTERVAL IN PATIENTS WITH COVID-19
por: Batemarco, Thomas, et al.
Publicado: (2022)

Interval‐based features of auditory ERPs for diagnosis of early Alzheimer's disease
por: Sabbaghi, Neda, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Computational and experimental studies on the inhibitory mechanism of hydroxychloroquine on hERG
por: Yu, Ran, et al.
Publicado: (2021)

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring
por: Ramireddy, Archana, et al.
Publicado: (2020)

Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
por: Bernardini, Andrea, et al.
Publicado: (2021)

Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19
por: Echarte-Morales, Julio, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT-interval prolongation and polymorphic ventricular tachycardia arrest due to off-label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine: Corrected QT interval prolongation, first degree atrioventricular block and left bundle branch block during an off-label treatment with hydroxychloroquine for COVID-19 pneumonia: 3 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Hydroxychloroquine and QT Prolongation in Older Patients with Rheumatic Diseases: Who is afraid of the Boogeyman? We are not!
por: Castagna, Alberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bla0vltusov9vqfuquk1lh8o3r